Rajan Sharma
Stock Analyst at Goldman Sachs
(0.16)
# 4,419
Out of 5,090 analysts
5
Total ratings
25%
Success rate
-22.98%
Average return
Main Sectors:
Top Industries:
Stocks Rated by Rajan Sharma
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| DBVT DBV Technologies | Reinstates: Sell | $7.25 | $13.90 | -47.84% | 1 | May 29, 2025 | |
| AZN AstraZeneca | Initiates: Buy | $97 | $90.18 | +7.56% | 1 | May 30, 2024 | |
| GSK GSK plc | Initiates: Neutral | $47 | $48.41 | -2.91% | 1 | May 30, 2024 | |
| IMCR Immunocore Holdings | Reiterates: Overweight | $79 | $38.78 | +103.71% | 2 | Jun 20, 2023 |
DBV Technologies
May 29, 2025
Reinstates: Sell
Price Target: $7.25
Current: $13.90
Upside: -47.84%
AstraZeneca
May 30, 2024
Initiates: Buy
Price Target: $97
Current: $90.18
Upside: +7.56%
GSK plc
May 30, 2024
Initiates: Neutral
Price Target: $47
Current: $48.41
Upside: -2.91%
Immunocore Holdings
Jun 20, 2023
Reiterates: Overweight
Price Target: $79
Current: $38.78
Upside: +103.71%